Abstract
The neurotransmitter dopamine has biological attributes that make it amenable to study by positron emission tomography, unlike many of the 40 or so neurotransmitters that have been identified in the brain. Dopamine deficiency in the nigrostriatal system is a characteristic of Parkinson's disease1, and a disturbance of dopamine metabolism is still widely held to be responsible for the syndrome of schizophrenia2. Despite its importance in the regulation of locomotion and mood, it has been impossible to visualize the intracerebral distribution of dopamine and measure its regional metabolism in man. In the first demonstration of the regional distribution of a neurotransmitter in the brain of conscious normal man, we show here that L-3,4-dihydroxyphenylalanine (L-dopa) labelled in the 6-position with the positron-emitting radionuclide fluorine-18, localizes specifically in the dopaminergic pathways of the human brain where its turnover could be measured atraumatically by positron emission tomography.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ehringer, H. & Hornykiewicz, O. Wien. klin. Wschr. 38, 1236–1239 (1960).
Haracz, J. L. Schizophrenia Bull. 8, 438–469 (1982).
Javoy-Agid, F. & Agid, Y. Neurology 30, 1326–1330 (1980).
Lindvall, O. & Bjorklund, A. Acta physiol. scand. Suppl. 412, 1–48 (1974).
Anden, N. E., Carlsson, A. & Haggendal, J. A. Rev. Pharmac. 9, 119–134 (1969).
Marsden, C. D. Lancet ii, 1141–1146 (1982).
Firnau, G., Nahmias, C. & Garnett, S. J. appl. Radiat. Isotopes 24, 182–184 (1973).
Firnau, G., Chirakal, R., Sood, S. & Garnett, E. S. Can. J. Chem. 58, 1449–1450 (1980).
Firnau, G., Garnett, E. S., Sourkes, T. L. & Missala, K. Experientia 31, 1254–1255 (1975).
Garnett, E. S., Firnau, G., Nahmias, C., Sood, S. & Belbeck, L. Am. J. Physiol. 238, R318–R327 (1980).
Firnau, G., Sood, S., Pantel, R. & Garnett, E. S. Molec. Pharmac. 19, 130–133 (1980).
Garnett, E. S., Nahmias, C., Kenyon, D. B. & Firnau, G. J. Can. Ass. Radiat. 33, 172–175 (1982).
Hardebo, J. E. & Owman, C. Ann. Neurol. 8, 1–11 (1980).
Marsden, C. D. in The Clinical Uses of Levodopa (ed. Stern, G.) 107–126 (University Park Press, Baltimore, 1975).
Goldman, P. Science 164, 1123–1130 (1969).
Garnett, E. S., Firnau, G., Nahmias, C. & Chirakel, R. Brain Res. (submitted).
Carlsson, A. Pharmac. Rev. 18, 541–549 (1966).
Marsden, C. D. Trends Neurosci. 3, 284–287 (1980).
Barchas, J. D., Akil, H., Elliott, G. R., Holman, R. B. & Watson, S. J. Science 200, 964–973 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garnett, E., Firnau, G. & Nahmias, C. Dopamine visualized in the basal ganglia of living man. Nature 305, 137–138 (1983). https://doi.org/10.1038/305137a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/305137a0
This article is cited by
-
Translational molecular imaging and drug development in Parkinson’s disease
Molecular Neurodegeneration (2023)
-
Arene radiofluorination enabled by photoredox-mediated halide interconversion
Nature Chemistry (2022)
-
Dopamine transporter (DAT) imaging in Parkinson’s disease and related disorders
Journal of Neural Transmission (2022)
-
Experience of 6-l-[18F]FDOPA Production Using Commercial Disposable Cassettes and an Automated Module
Nuclear Medicine and Molecular Imaging (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.